A new method for the evaluation of vaccine safety based on comprehensive gene expression analysis

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Momose, Haruka ^a   Mizukami, Takuo ^a   Ochiai, Masaki ^a   Hamaguchi, Isao ^a   Yamaguchi, Kazunari ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; PERTUSSIS VACCINE; SODIUM CHLORIDE; VACCINE;

ANIMAL TESTING ALTERNATIVE; AVIAN INFLUENZA; DNA MICROARRAY; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; HUMAN; JAPANESE ENCEPHALITIS; LEUKOCYTE COUNT; LEUKOPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERTUSSIS; QUALITY CONTROL; RAT; REVIEW; WEIGHT CHANGE; ANIMAL; CLUSTER ANALYSIS; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION PROFILING; METHODOLOGY; MOUSE; STANDARD;

ANIMALIA; RATTUS;

ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUALITY CONTROL; RATS; VACCINES;

EID: 77954553788     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/361841     Document Type: Review

References (24)

1. Horiuchi Y., Takahashi M., Konda T., Quality control of diphtheria tetanus acellular pertussis combined (DTaP) vaccines in Japan Japanese Journal of Infectious Diseases 2001 54 5 167 180
2. Kurokawa M., Toxicity and toxicity testing of pertussis vaccine Japanese Journal of Medical Science and Biology 1984 37 2 41 81
3. Mizukami T., Masumi A., Momose H., An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan Biologicals 2009 37 1 8 17
4. Lettieri T., Recent applications of DNA microarray technology to toxicology and ecotoxicology Environmental Health Perspectives 2006 114 1 4 9
5. Lobenhofer E. K., Bushel P. R., Afshari C. A., Hamadeh H. K., Progress in the application of DNA microarrays Environmental Health Perspectives 2001 109 9 881 891
6. Pennie W., Pettit S. D., Lord P. G., Toxicogenomics in risk assessment: an overview of an HESI collaborative research program Environmental Health Perspectives 2004 112 4 417 419
7. Harrill A. H., Rusyn I., Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity Expert Opinion on Drug Metabolism Toxicology 2008 4 11 1379 1389
8. Hamadeh H. K., Bushel P. R., Jayadev S., Gene expression analysis reveals chemical-specific profiles Toxicological Sciences 2002 67 2 219 231
9. Ejiri N., Katayama K.-I., Kiyosawa N., Baba Y., Doi K., Microarray analysis on phase II drug metabolizing enzymes expression in pregnant rats after treatment with pregnenolone-16 -carbonitrile or phenobarbital Experimental and Molecular Pathology 2005 79 3 272 277 (Pubitemid 41566244)
10. European Medicines Agency Concept Paper, Pharmacogenomics (PG) biomarker qualification: format and data standards Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use June 2008. EMEA/CHMP/190395/2008, http://www.emea.europa.eu/pdfs/human/pharmacogenetics/19039508en.pdf
11. Frueh F. W., Impact of microarray data quality on genomic data submissions to the FDA Nature Biotechnology 2006 24 9 1105 1107
12. Minimum Requirements for Biological Products 2006 Tokyo, Japan National Institute of Infectious Diseases. http://www.nih.go.jp/niid/MRBP/files/ seibutsukienglish.pdf
13. Kurokawa M., Ishida S., Asakawa S., Iwasa S., Goto N., Toxicities of influenza vaccine: peripheral leukocytic response to live and inactivated influenza viruses in mice Japanese Journal of Medical Science and Biology 1975 28 1 37 52
14. Chino F., The views and policy of the Japanese control authorities on the three Rs Developments in Biological Standardization 1996 86 53 62
15. Hamaguchi I., Imai J.-I., Momose H., Two vaccine toxicity-related genes Agp and Hpx could prove useful for pertussis vaccine safety control Vaccine 2007 25 17 3355 3364
16. Mizukami T., Imai J.-I., Hamaguchi I., Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation Vaccine 2008 26 18 2270 2283
17. Hamaguchi I., Imai J.-I., Momose H., Application of quantitative gene expression analysis for pertussis vaccine safety control Vaccine 2008 26 36 4686 4696
18. Ito E., Honma R., Imai J.-I., A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor American Journal of Pathology 2003 163 6 2165 2172
19. Kobayashi S., Ito E., Honma R., Dynamic regulation of gene expression by the Flt-1 kinase and Matrigel in endothelial tubulogenesis Genomics 2004 84 1 185 192
20. Edwards K. M., Decker M. D., Plotkin S. A., Orenstein W. A., Offit P. A., Pertussis vaccines Vaccines 2008 5th New York, NY, USA Elsevier 467 517
21. Sato H., Sato Y., Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system Infection and Immunity 1984 46 2 415 421
22. Bridges C. B., Katz J. M., Levandowski R. A., Cox N. J., Plotkin S. A., Orenstein W. A., Offit P. A., Inactivated influenza vaccines Vaccines 2008 5th New York, NY, USA Elsevier 259 290
23. Ungchusak K., Auewarakul P., Dowell S. F., Probable person-to-person transmission of avian influenza A (H5N1) The New England Journal of Medicine 2005 352 4 333 340
24. Momose H., Imai J.-I., Hamaguchi I., Induction of indistinguishable gene expression patterns in rats by Vero cell-derived and mouse brain-derived Japanese encephalitis vaccines Japanese Journal of Infectious Diseases 2010 63 1 25 30